fda and semaglutide compounding stops fda stopping compounded semaglutide FDA is moving to restrict mass-marketed compounded FDA moves to limit compounding

After a particularly unsatisfying trip to Sedona, AZ, where I didn't feel up to doing my usual hiking, I realized that I needed to do something

For instance, in clinical trials with tirzepatide (marketed as Mounjaro or Zepbound), over half of the participants lost more than 20% of their body weight

Not the peptide source

Specialized tests, however, may detect these drugs, particularly in clinical or sports environments

Front Neurosci 14:583097 King MR, Anderson NJ, Deciu M, Guernsey LS, Cundiff M, Hajizadeh S, Jolivalt CG (2020) Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins

Im really glad I did